YKL‐40 protein in osteosarcoma tumor tissue

APMIS - Tập 124 Số 6 - Trang 453-461 - 2016
Andrea Thorn1,2, Søren Daugaard1, Lise Christensen3, Ib Jarle Christensen3, Michael Mørk Petersen2
1Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
2Musculoskeletal Tumor Section, Department of Orthopedic Surgery, University of Copenhagen, Copenhagen, Denmark
3Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

Tóm tắt

YKL‐40, a cellular glycoprotein isolated from the human osteosarcoma (OS) cell line MG63, is increased in the blood of patients with various types of cancer, and is found as an independent prognostic variable for survival. YKL‐40 is also present with variable intensity in the tumor cells of some cancer types, but survival results have been conflicting. The aim of this study was to investigate the tissue expression of YKL‐40 and its possible role as a predictive marker in patients with OS. Forty‐eight patients were included in the study. Diagnostic biopsies were analyzed by immunohistochemistry; YKL‐staining scores as well as CD14 and CD163 scores were determined, and survival data were determined statistically. A universal intense immunostaining for YKL‐40 was found in all tumor cells, but tumor cell/stroma ratio varied, and this ratio (%) served as staining score. Using 24% as mean score to divide the material, patients with tumors of high YKL‐40 score had a better survival than patients with low score (p = 0.05). YKL‐positive macrophages had no influence on the result. Unexpectedly and contrary to some other findings in cancer tissues, this study has shown a correlation between high YKL‐40 tumor cell/matrix ratio and longer overall survival in OS.

Từ khóa


Tài liệu tham khảo

10.1007/s10735-006-9075-0

10.1002/jbmr.5650070506

Aggerholm‐Pedersen N, 2014, The importance of standardized treatment in high‐grade osteosarcoma: 30 years of experience from a hospital‐based database, Acta Oncol, 54, 1

10.1369/jhc.7A7245.2007

10.1084/jem.20081271

10.1002/ijc.23313

10.1038/onc.2009.292

Johansen JS, 2006, Studies on serum YKL‐40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer, Dan Med Bull, 53, 172

10.3389/fphys.2013.00122

10.1158/1055-9965.EPI-05-0011

10.1016/j.urolonc.2014.02.004

10.1007/s10549-007-9870-7

10.1186/1471-2407-9-8

10.1016/j.prp.2011.06.008

10.1016/S1499-3872(11)60103-3

10.1371/journal.pone.0051127

10.1007/s13277-013-1036-0

10.1016/j.humpath.2009.07.005

10.1158/1078-0432.CCR-04-1765

Yang GF, 2009, Expression and clinical significance of YKL‐40 protein in epithelial ovarian cancer tissues, Ai Zheng, 28, 142

10.1111/j.1600-0463.2009.02461.x

10.3109/17453674.2014.893496

10.1097/PAI.0b013e3181b0eaad

10.1016/j.ejso.2009.01.011

10.1200/JCO.2002.20.3.776

10.1158/1078-0432.CCR-10-2047

10.1245/s10434-013-3210-4

10.1111/j.1743-7563.2012.01560.x

10.1016/j.ejca.2009.03.005

10.1007/s12032-013-0624-6

10.1097/BLO.0b013e318059b8c9

10.1097/01.blo.0000179736.10871.76

10.1517/14656566.2013.827171

10.2106/JBJS.L.00955

10.1158/1055-9965.EPI-07-2766

Thông tin
Thông tin xuất bản

APMIS

Tập 124 Số 6

453-461

Thông tin tác giả